| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |